Opioid Stewardship Davies Presentation

Similar documents
Saving & Changing Lives: Ochsner s Opioid Stewardship Program

Buprenorphine Order Set and Rapid Access Referral. Copyright 2017, CAMH

Medicaid and the Opioid Crisis

Treating Emergency Room Opioid Withdrawal with Buprenorphine

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Six Building Blocks Self-Assessment Questionnaire Workshop Version July 2017

6/6/2017. First Do No Harm SECTION 1 THE OPIOID CRISIS. Implementing an Opioid Stewardship Program in a HealthCare System OBJECTIVES

Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System

Management Options for Opioid Dependence:

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4)

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

Opioid Abuse and Prescribing. Dr. Mitchell Mutter Director of Special Projects

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

Morrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence

PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION. Chronic Pain and Opiate Management Initiatives

S 0332 S T A T E O F R H O D E I S L A N D

The Opioid Epidemic and How It is Impacting the Workplace. July 24, 2018

2 nd Bernalillo County Opioid Abuse Accountability Summit Data Series January 8, 2015

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

UT HEALTH S RESPONSE TO

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

Aetna s Initiative on the Opioid Epidemic

Blue Cross of Idaho Addresses State s Opioid Issue

Proposed Revision to Med (i)

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

The Opioid Epidemic: The State of the State

Opioid Crisis, Our Response Massachusetts Coalition for the Prevention of Medical Errors. October 31, 2016

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

Medication Assisted Treatment. Nicole Gastala, MD

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2017 (2017Q3)

Public Policy and Best Practices for Reducing Opioid Harm. State Capital Building, Harrisburg PA June 6, 2018

Prepublication Requirements

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

In-House Chronic Pain and Opioid Use Reporting Guide

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / /

Opioid Overdose Education and Naloxone Distribution

Oregon Prescription Drug Monitoring Program

IntNSA Webinar Series

Taos Alive. Improving a Community in Pain By Julie Martinez CPS

Oregon Opioid Overdose Prevention Initiative

Risk Classification Modeling to Combat Opioid Abuse

What is the strategy?

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Addressing the Opioid Crisis An ACH Collaboration

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Opioid Review and MAT Clinic CDC Guidelines

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

Prescription Monitoring Program (PMP)

SUBHEAD GOES HERE. Addressing Tennessee s Opioid Crisis. Natalie A. Tate, PharmD Vice President, Pharmacy

S 2356 SUBSTITUTE A AS AMENDED ======== LC004564/SUB A/3 ======== S T A T E O F R H O D E I S L A N D

The Role of Urgent Care in responding to the opioid Crisis

Coalition Strategies Across The Continuum of Care

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

Federal-State Response to the Opioid Crisis. Session 48 February 12, 2019

NBPDP Drug Utilization Review Process Update

Chronic Pain Management in the Primary Care Setting

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

TESTIMONY Of Pam Gehlmann Executive Director/ Assistant Regional Director Pinnacle Treatment Centers Alliance Medical Services-Johnstown

Opioid Prescribing Improvement Program

The Opioid Crisis in Kentucky. Doug Oyler, PharmD Director, Office of Opioid Safety UK HealthCare

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

Implementing Pain and Opioid Management Guidelines in Primary Care Practice

Opioid epidemic and PEHP

Safina Koreishi, MD, MPH, Medical Director, Columbia Pacific CCO

Maine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016

PERSPECTIVE FROM VIRGINIA: SUCCESS ADDRESSING THE OPIOID CRISIS THROUGH MEDICAID ADDICTION AND RECOVERY TREATMENT SERVICES (ARTS)

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

Cynthia B. Jones, Director Department of Medical Assistance Services (DMAS)

September 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Population health: Going beyond primary care, making it work in a complex health system. Mary Brainerd, HealthPartners President and CEO

The Opioid Crisis: Effectiveness of State Responses

The MetroHealth System. Creating the HIT Organizational Culture at MetroHealth. Creating the HIT Organizational Culture

Applying Population Health Management to Opiate Prescription Medication Misuse

Narcotic Stewardship Project

Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative

is rarely visible, and communication about use of opioids for chronic pain patients is ad hoc and informal.

E-Prescribing, EPCS & PDMP: An Update

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

The Opioid Crisis Made in America Fade in America?

Changing Course: statewide efforts to combat the opioid epidemic in California

The Impact of Opioid Use and Abuse on Medical Community, Businesses, Social Organizations and Individiuals and Their Families

Solving America s Prescription Epidemic

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System

Clinical Safety & Effectiveness Cohort # 11

PRESCRIBING GUIDELINES

Transcription:

Opioid Stewardship Davies Presentation Todd Burstain, MD CMIO Ochsner Health Systems Deborah Simonson, Pharm D. Vice President, Pharmacy Ochsner Health Systems Richard Guthrie, MD Chief Quality Officer Ochsner Health Systems

The Start of an Epidemic

The Opioid Crisis Nationally and Locally 63,632 Americans died in 2016 from Drug Overdose 66% from prescription/illicit opioids Prescription opioid overdose death rate up 10.6% (2015-6) 21-29% of patients given opioids for chronic pain end up misusing them 80% of patients abusing Heroin began with abusing prescription opioids 2003 to 2013 Neonatal Abstinence Syndrome in La increased by 380% Economic cost to US over $78 billion/year Deaths from overdose > homicide in Orleans Parish 2016 6 th highest rx/pt in US in LA at 1.02 rx/person in state

Opioid Crisis at Ochsner Slow steady rise in opiate prescription Values Patient First, Compassion, Integrity, Excellence and Teamwork Mission Heal, Serve, Lead, Educate and Innovate Vision leader who will change and save lives

Overall Strategy Build Governance Structure Educate Providers and Patients Why is it important What is best practice Provide analytic feedback data Target Key areas Build Best Practice into Epic Hardwire workflows Intelligent Decision Support Develop Community Resources Report on Success of Intervention

The Ochsner Opioid Stewardship Team Team Lead Strategic Program Manager Opioid Stewardship Committee Hospital Opioid Stewardship ED Opioid Stewardship Opioid Diversion Urgent Care Opioid Stewardship Clinic Opioid Stewardship Dependency Treatment and Recovery Pain Treatments Service Line Opioid Management

Building up the volume

Patient and Provider Education

First Blinded data, then remove the blindfolds 40% decline in opioid rxs

MEQ/Rx and % following guideline (3d/rx) ED Alignment To Guidelines

Patient Experience Mean Score Initial Resistance: HCAHPS Physicians Who Prescribe Less Have Same Patient Experience Opioid Prescribing Rate vs. Press Ganey Mean Score by Physician 100 95 90 85 80 75 70 0% 5% 10% 15% 20% 25% 30% 35% 40% Opioid Prescribing Rate To Ease Fears, Removed Patient Satisfaction for Pain Despite Lack of Correlation

Expand the Pilot Inpatient OB discharges Hardwire into D/C Ordersets OB Adherence to Guideline (3d/rx)

Not just less prescribing, better prescribing Identify low risk vs high risk patients What did literature say Design best way to monitor patients getting opioids Minimize risk Monitor for misuse Communicate expectations with patients Hardwire best practices into workflow Monitor results and provide feedback

Can we identify who is at risk for misuse? Opioid Risk Tool Questionnaire University of Utah 5.6% of low risk patients developed misuse of opioid 90.9% of high risk patients developed misuse of opioids Coefficient 0.82 for males, 0.85 for females

Custom Built Opioid Management Activity in Epic Minimize End User Data Entry Auto Flags based on Problem List Auto Flags based on Family Hx Auto Flags based on Social Hx Differentiates between validated and nonvalidated scores

Opioid Risk Tool Report and Explanation

Opioid Management Tool - Resources

Direct Links to Patient Assessment PEG 3 and PHQ 4

Tracking over Time

Displaying the Score to End User

Epic Referrals and Documentation BPA for mod/high risk patients for placing referral orders Smartphrase to pull documentation into note

How strong is that prescription? Concept of Morphine Equivalents Daily Dose (MEDD) Issues of prn sig on prescriptions Complexities of Methadone in MEDD

Best Practice of Care Based on Risk Separating acute from chronic users Minimizing Risk Naloxone Prescription Opioid Risk Tool Evaluation Monitoring Compliance Urine Drug Screens Communicating Expectations with Patients Pain Contracts Using tools End Users Familiar With Health Maintenance

Separating Acute from Chronic Users Rule based on 3 active rx for opioid in last 4 months Age > 18 (had age limit of 80 but removed this later) Not on hospice care No active diagnosis of cancer Inclusion rule added patients to registry based on risks Low risk ORT score low, no hx of substance abuse, MEDD<90, no concomitant benzodiazepine use Med risk ORT score medium, no hx of substance abuse, MEDD<90, no concomitant benzodiazepine use High risk ORT score high, or hx of substance abuse or MEDD>=90 or concomitant benzodiazepine use Vetted results with sample end users to confirm accuracy

Patient Letter Send to: All patients receiving opioids for 3 of the last 4 months Once we figure out the roll out date we can back into this Send to: All patients receiving opioids from a provider who no longer works for us Ongoing basis Delivery Mechanism: Mail to patients directly Each Primary Care location print the letter on their letterhead so their patients have the clinic number readily available at the top of the letter Education: Notify Providers at Primary Care Council meeting (prior to letter going live ) Tracking: Track letter delivery/sent through MyChart and Letters Tab 25

Breakdown of Chronic Opioid Users 9000 8000 Chronic Opioid Use Patients 8062 7000 6000 5724 5000 4000 3000 2000 1832 1000 0 506 Low Risk Med Risk High Risk Total Patients

Breakdown of Chronic Opioid Use by Age 35.00% Patients 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 18-30 31-40 41-50 51-60 61-70 71-80 >80 Patients

Various Diagnosis among Chronic Opioid Users 72% had some pain disorder on Problem List 40.00% 35.00% 35.60% 30.00% 25.00% 20.00% 26.80% 22.40% 15.00% 10.00% 10.60% 5.00% 0.00% 2.80% 1.90% 3.40% 0.70% 2.10% Patients

Narcotic Prescribed and Benzodiazepine Use 70% 60% 66% % Patients on Rx in last 6 months 50% 40% 30% 37.20% 42.40% 20% 10% 0% 11.90% 0.50% 0.30% 8% 1.70% % Patients

Health Maintenance Topic Rules Low Risk ORT completed Pain Contract signed Medium Risk Same as low UDS yearly High Risk Same as low UDS every 6 months Naloxone rx yearly

Ad hoc modifiers Created so can add patients to HM even if not in system for 3 months yet Can exclude patients to HM by modifiers as well Allowed physician discretion

Building Out Health Maintenance Rules

Build HM into HM Overdue SmartSet

Integrating Pain Contract Documents Created document type of pain contract for scanned documents Fax form with standard contract available via one click link Trained staff and HIM to scan documents into media tab

Louisiana Legislation Act # 76 (Senate Bill 55) Requires Accessing a Patient s PMP Every 90 Days for Patients on Opioids >90 Days. Auto Enroll Prescribers into the PMP Who Get a New License and at Renewal (Every 3 Years) Require 3 Hours of Continuing Education Prior to License Renewal* Act # 82 (House Bill 192) Limit Opioid Prescriptions to Seven Days for a Patient s First Prescription** Acute Pain (adults) ANY TIME (minors) Providers must to do both of the following prior to issuing a prescription for an opioid: 1. Consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity. 2. Inform the patient of the risks associated with the opioid prescribed. Act # 88 (House Bill 490) Created an Advisory Council on Heroin and Opioid Prevention and Education

Monitor for Misuse with PMP Link Identify vendor for HIE Appriss Develop call out protocol and matching criteria Mark in Employee record who has PMP access One click solution Information Technology Academy Journal 4/18

In application PMP report viewing

Doing Our Part: Drug Diversion Response Team Use Data Analytics to Audit Internal Controlled Substance Utilization Investigate Any Reports of Drug Diversion or Loss of Controlled Substances Monthly Interdepartmental Meeting Representation from Pharmacy, Nursing, Compliance, Legal, and Pain Management In Pilot Phase- Plan to Expand to All Ochsner Sites in 2018

Innovative Approaches to Pain Treatment Healthy Back Program 10 Week Program- Two Times Per Week Patients Reported a 62.5% Decrease in Pain After 10 Weeks of Treatment Medicaid Grants to Provide Services Not Usually Covered: PT Paravertebral Facet Joint Blocks Virtual Reality to Reduce Initial Exposure to Opioids

Functional Restoration Program Outpatient, Multidisciplinary, Three-Week Program Includes: Pain Medicine, Pain Psychiatry Specialists, Physical & Occupational Therapists, Social Workers & Nutrition Coaches Focus on Reclaiming Function & Patient-Centered Goals Program Currently Completing 6 th Cohort, 30-days After Program, Patients Report: 51% Decrease in Disability Due to Pain 32% Improvement in Sleep 63% Improvement in Mood

Opioid Free Cases Opiate Free Protocol Cases > 2 Hours Pre-operative IV Acetaminophen and IV Ibuprofen Started with Colorectal & Urology Procedures Other Procedures to Limit Opioid Use: Knee & Hip Replacements

Expanding Opioid Use Disorder Treatment Options Our New Psychiatric Hospital- River Place Behavioral Health- Will Open a Dual Diagnosis Unit in 2018 Offering Detoxification and Induction with Buprenorphine for Opioid Dependent Patients with Acute Psychiatric Issues Psychiatry's Suboxone Program (OchMAT) is Underway Adding Additional Support to Capture a Greater Range of Disease Severity. Intensive Outpatient Program for Substance Use (Addictive Behavior Unit) is Streamlining its Services for Opioid Dependent patients Providing Easier Access to Outpatient Suboxone Treatment.

Partnerships with Treatment Facilities

Outcomes Prescription rates Guideline Compliance PMP registration Best Practice Health maintenance ORT Pain Contracts UDS Naloxone Rx Expansion Concomitant benzodiazepine usage

ED Prescription Data (Began at 105 MEQ/rx and 50% guideline alignment (3d/rx)) % Alignment to Guideline

OB Prescription Data Alignment to Guideline (3d/rx) % Alignment to Guideline

% Alignment to Guideline Urgent Care Prescription Data Alignment to Guideline (3d/rx)

System Wide Prescription Data % Patients Seen in Office/ED/Hosp given Opioid 26,000 fewer patients on Opioids ED Reporting MEDD Go live HM Go live

System Wide Prescription Office Visit Only ED Reporting MEDD Go live HM Go live

System Wide Prescription ED Only ED Reporting MEDD Go live HM Go live

PMP Registration 90% % PMP access 80% 70% 60% 50% 40% 30% 20% 10% 0% Jan Feb Mar Apr May June % PMP access

Health Maintenance Outcomes Low Risk 30% % Patients 25% 20% 24% 21.10% 15% 14% 10% 5% 0% ORT completed Pain contract Both done % Patients

Health Maintenance Outcomes Med Risk 70% 60% 64% % Patients 50% 40% 30% 36.60% 31% 20% 18.20% 10% 0% ORT completed Pain contract Urine Screen All 3 % Patients

Health Maintenance Outcomes High Risk 40% 35% 30% 25% 20% 15% 10% 5% 0% 35% 24.60% % Patients 17% 15% 4.80% % Patients

Frequency of Urine Drug Screening 22% increase 800 700 Avg tests/month 715 600 585 500 400 300 200 100 0 Pre HM Avg tests/month Post HM

Naloxone Prescriptions 101% increase Avg Rx/month 100 90 90.4 80 70 60 50 44.9 40 30 20 10 0 Pre HM Post HM Avg Rx/month

Non Heroin OD of Opiate in ED and Survival 4.2 deaths/quarter pre HM/MEDD, 1.75 deaths/quarter post HM/MEDD MEDD Go live

% Deceased Non Heroin Opioid OD in ED 16% % Fatal 14% 12% 10% MEDD Go live 8% 6% 4% 2% 0% 2015 q1 2015 q2 2015 q3 2015 q4 2016 q1 2016 q2 2016 q3 2016 q4 2017 q1 2017 q2 2017 q3 2017 q4 2018 q1 2018 q2 % Fatal Linear (% Fatal)

Publishing Results